Cargando…
Pharmacokinetics, Tissue Distribution, Plasma Protein Binding Studies of 10-Dehydroxyl-12-Demethoxy-Conophylline, a Novel Anti-Tumor Candidate, in Rats
10-Dehydroxyl-12-demethoxy-conophylline is a natural anticancer candidate. The motivation of this study was to explore the pharmacokinetic profiles, tissue distribution, and plasma protein binding of 10-dehydroxyl-12-demethoxy-conophylline in Sprague Dawley rats. A rapid, sensitive, and specific ult...
Autores principales: | Jiang, Chengjun, Li, Jie, Cai, Xianghai, Li, Nini, Guo, Yan, Wang, Dianlei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359039/ https://www.ncbi.nlm.nih.gov/pubmed/30646543 http://dx.doi.org/10.3390/molecules24020283 |
Ejemplares similares
-
Conophylline inhibits non-alcoholic steatohepatitis in mice
por: Nakade, Yukiomi, et al.
Publicado: (2017) -
Renewable Chemicals: Dehydroxylation of Glycerol and Polyols
por: ten Dam, Jeroen, et al.
Publicado: (2011) -
Proline-promoted dehydroxylation of α-ketols
por: Mostinski, Yelena, et al.
Publicado: (2019) -
Conophylline inhibits high fat diet-induced non-alcoholic fatty liver disease in mice
por: Ohashi, Tomohiko, et al.
Publicado: (2019) -
Conophylline suppresses pancreatic cancer desmoplasia and cancer‐promoting cytokines produced by cancer‐associated fibroblasts
por: Ishii, Norihiro, et al.
Publicado: (2018)